Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02744235
Other study ID # 15-00071
Secondary ID
Status Withdrawn
Phase N/A
First received April 13, 2016
Last updated April 25, 2017
Start date March 2016
Est. completion date April 2017

Study information

Verified date April 2017
Source New York University School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare two popular portable sleep monitoring devices—the Fitbit Charge®, Jawbone UP®, and SleepTime smartphone app—to the "gold standard" Polysomnography (PSG). Parameters that will be analyzed include sleep onset latency, sleep efficiency, and sleep staging. Specifically, this study will investigate the validity of the Jawbone UP®, Fitbit Charge®, and SleepTime app in detecting sleep and wakefulness in comparison to conventional Polysomnography (PSG).


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date April 2017
Est. primary completion date April 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Patients undergoing Polysomnography

Exclusion Criteria:

- severe sleep apnea

- severe insomnia with less than two hours of sleep per night

- epileptiform activity

- electrical status epilepticus of sleep

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Polysomnography Data

Jawbone UP®

Fitbit Charge ®


Locations

Country Name City State
United States New York University School of Medicine New York New York

Sponsors (1)

Lead Sponsor Collaborator
New York University School of Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time it takes subject to fall asleep Up to 3 Months
Primary Number of Minutes of Sleep Up to 3 Months
Primary Number of Arousals Up to 3 Months